West Pharmaceutical Services (WST) share buybacks: $134M
West Pharmaceutical Services spent $134M buying back its own shares in the year ended Dec 31, 2025, down 76.1% from $561M a year earlier.
From West Pharmaceutical Services's filings with the SEC · Read the filing · WST stock page
West Pharmaceutical Services share buybacks by year
#711 of 1,890 US companies by share buybacks · See the full ranking
| Year ended | Share buybacks | Change |
|---|---|---|
| Dec 31, 2025 | $134M | -76% |
| Dec 31, 2024 | $561M | +28% |
| Dec 31, 2023 | $438M | +116% |
| Dec 31, 2022 | $203M | +48% |
| Dec 31, 2021 | $137M | – |
Share buybacks of similar companies
Companies in the same industry as West Pharmaceutical Services, by SEC industry code, with the closest share buybacks. Each name opens the same page for that company.
| Company | Share buybacks, latest year | Year ended |
|---|---|---|
| Dexcom | $500M | Dec 31, 2025 |
| Globus Medical | $300M | Dec 31, 2025 |
| Teleflex | $300M | Dec 31, 2025 |
| Inspire Medical Systems | $175M | Dec 31, 2025 |
| Haemonetics | $175M | Mar 28, 2026 |
| West Pharmaceutical Services | $134M | Dec 31, 2025 |
| Insulet | $59.6M | Dec 31, 2025 |
Questions and answers
What is West Pharmaceutical Services's share buybacks?
West Pharmaceutical Services spent $134M buying back its own shares in the year ended Dec 31, 2025, down 76.1% from $561M a year earlier.
Numbers as reported in West Pharmaceutical Services's annual and quarterly reports to the SEC (XBRL data). A year is the company's fiscal year that falls mostly in that calendar year; balances such as cash and debt are as of the date shown. Data only, not investment advice. Methodology